Dr Mohammad Muhsin Chisti, MD - Oakland University William Beaumont School of Medicine - Assistant Professor

Dr Mohammad Muhsin Chisti

MD

Oakland University William Beaumont School of Medicine

Assistant Professor

Bloomfield Hills, MI, MI | United States

Main Specialties: Hematology & Oncology

Additional Specialties: Hematology Oncology


Top Author

Dr Mohammad Muhsin Chisti, MD - Oakland University William Beaumont School of Medicine - Assistant Professor

Dr Mohammad Muhsin Chisti

MD

Introduction

Primary Affiliation: Oakland University William Beaumont School of Medicine - Bloomfield Hills, MI, MI , United States

Specialties:

Additional Specialties:

Research Interests:

Metrics

Number of Publications

9

Publications

Number of Profile Views

1262

Profile Views

Number of Article Reads

135

Reads

Number of Citations

12

Citations

Education

Jun 2013
Oakland University William Beaumont School of Medicine
Hematology Oncology
Jul 2010
Roswell Park Cancer Institue, Buffalo, NY
Hematology Oncology
Jun 2008
University At Buffalo, NY
Internal Medicine

Top co-authors

Alaa Muslimani
Alaa Muslimani

Fairview Hospital

3
Ishmael Jaiyesimi
Ishmael Jaiyesimi

William Beaumont Hospital

3
Siddhartha Yadav
Siddhartha Yadav

Department of Internal Medicine

2
Laura Nadeau
Laura Nadeau

Beaumont Cancer Institute

2
James Huang
James Huang

Memorial Sloan Kettering Cancer Center

2
Muhammad Fahad Khan
Muhammad Fahad Khan

University of Arizona

1
Ann Marie Blenc
Ann Marie Blenc

Oakland University William Beaumont School of Medicine

1
Dana Zakalik
Dana Zakalik

Nancy and James Grosfeld Cancer Genetics Center

1

Publications

9Publications

135Reads

12PubMed Central Citations

General Signal Amplification Strategy for Nonfaradic Impedimetric Sensing: Trastuzumab Detection Employing a Peptide Immunosensor.

Anal Chem 2017 Apr 20;89(7):4013-4020. Epub 2017 Mar 20.

Department of Chemistry, Oakland University , Rochester, Michigan 48309, United States.

View Article
April 2017
39 Reads
2 Citations
5.640 Impact Factor

Pulmonary infiltrates in acute myeloid leukemia during induction treatment: how much do we know?

Am J Clin Oncol 2014 Aug;37(4):377-83

Departments of *Hematology and Oncology †Radiation Oncology ‡Pathology, Oakland University William Beaumont School of Medicine, William Beaumont Hospital, Royal Oak, MI.

View Article
August 2014
15 Reads
2.611 Impact Factor

Intravascular large B cell lymphoma presenting as cholecystitis: diagnostic challenges persist.

Ann Hematol 2014 Jul 28;93(7):1259-60. Epub 2013 Nov 28.

Department of Internal Medicine, Beaumont Health System, 3601 W 13 Mile Rd, Royal Oak, MI, 48073, USA,

View Article
July 2014
11 Reads
2 Citations
2.634 Impact Factor

Dasatinib-induced haemorrhagic colitis in chronic myeloid leukaemia (CML) in blast crisis.

BMJ Case Rep 2013 Dec 12;2013. Epub 2013 Dec 12.

Department of Hematology and Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.

View Article
December 2013
12 Reads
1 Citation

Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed?

BMJ Case Rep 2013 Oct 29;2013. Epub 2013 Oct 29.

Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA.

View Article
October 2013
14 Reads

Peripheral T-cell lymphoma in a patient with Crohn's disease.

BMJ Case Rep 2013 Oct 10;2013. Epub 2013 Oct 10.

Department of Internal Medicine, DMC Sinai Grace Hospital, Detroit, Michigan, USA.

View Article
October 2013
12 Reads

Cardiac paraganglioma: clinical presentation, diagnostic approach and factors affecting short and long-term outcomes.

Int J Cardiol 2013 Jun 30;166(2):315-20. Epub 2012 May 30.

Southern Arizona VA Medical Center, Tucson, AZ, USA.

View Article
June 2013
10 Reads
3 Citations
4.040 Impact Factor

Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon.

Ann Hematol 2012 Sep 12;91(9):1485-7. Epub 2012 Jan 12.

View Article
September 2012
10 Reads
2 Citations
2.634 Impact Factor

How we treat tumor lysis syndrome.

Oncology (Williston Park) 2011 Apr;25(4):369-75

Department ofHematology/Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.

View Article
April 2011
12 Reads
2 Citations
2.981 Impact Factor

Top co-authors

Alaa Muslimani
Alaa Muslimani

Fairview Hospital

3
Ishmael Jaiyesimi
Ishmael Jaiyesimi

William Beaumont Hospital

3
Siddhartha Yadav
Siddhartha Yadav

Department of Internal Medicine

2
Laura Nadeau
Laura Nadeau

Beaumont Cancer Institute

2
James Huang
James Huang

Memorial Sloan Kettering Cancer Center

2
Muhammad Fahad Khan
Muhammad Fahad Khan

University of Arizona

1
Ann Marie Blenc
Ann Marie Blenc

Oakland University William Beaumont School of Medicine

1
Dana Zakalik
Dana Zakalik

Nancy and James Grosfeld Cancer Genetics Center

1

Followers